CollPlant Biotechnologies Ltd. (CLGN) Financials
CLGN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 37.6 million | 5.2 million |
2023-06-30 | 41.6 million | 5.5 million |
2023-03-31 | 35.8 million | 5.9 million |
2022-12-31 | 35.8 million | 5.9 million |
CLGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 6.5 million | 521000 |
2023-06-30 | -4.1 million | 338000 |
2023-03-31 | -3.6 million | 514000 |
2022-12-31 | -3.6 million | 514000 |
CLGN Net Income
No data available :(
CLGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 29.0 million | - | 3.1 million |
2023-06-30 | 22.3 million | - | 3.3 million |
2023-03-31 | 26.5 million | - | 3.5 million |
2022-12-31 | 26.5 million | - | 2.9 million |
CLGN Shares Outstanding
CLGN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 243000 | 2.7 million | 1.7 million | - |
2023-06-30 | 337000 | 2.6 million | 1.3 million | - |
2023-03-31 | 145000 | 2.1 million | 1.5 million | - |
2022-12-31 | 145000 | 2.1 million | 2.0 million | - |
CLGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 43000 | 278000 |
2023-06-30 | 10.2 million | 615000 |
2023-03-31 | 433000 | 325000 |
2022-12-31 | 433000 | 325000 |
CLGN
Price: $5.85
52 week price:
Earnings Per Share: -0.62 USD
P/E Ratio: -9.35
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 28000
Market Capitalization: 60.1 million